| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/15/2007 | US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 05/15/2007 | US7217825 Neutralizing an acidified solution of a water-miscible solvent and 2-butyl-3-[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl methyl]-1,3-diazaspiro[4.4]non-1-ene-4-one, a novel intermediate of a Suzuki coupling reaction; acidifying and cooling the second solution and recovering irbesartan |
| 05/15/2007 | US7217729 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies |
| 05/15/2007 | US7217722 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| 05/15/2007 | US7217718 Administering an immunosuppressant; therapy for autoimmune disease |
| 05/15/2007 | US7217716 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate NR2B antagonists |
| 05/15/2007 | US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses |
| 05/15/2007 | US7217713 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 05/15/2007 | US7217712 4-Substituted-5-cyano-1H-pyrimidin-6-(thi)ones as GSK-3 inhibitors |
| 05/15/2007 | US7217707 Amide of R-2-(aminoaryl)-propionic acid for use in the prevention of leucocyte activation |
| 05/15/2007 | CA2155275C Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds |
| 05/15/2007 | CA2148612C 2-fluoroalkyl-substituted benzimidazoles, their preparation and their use as pesticides |
| 05/15/2007 | CA2116167C One-component coating compositions containing oxime- or lactam-blocked polyisocyanates which have improved resistance to yellowing |
| 05/10/2007 | WO2007053819A2 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods |
| 05/10/2007 | WO2007053662A1 Dihydroisoindolones as allosteric modulators of glucokinase |
| 05/10/2007 | WO2007053657A1 Substituted pyrrolones as allosteric modulators of glucokinase |
| 05/10/2007 | WO2007053503A1 Substituted dihydroisoindolones as allosteric modulators of glucokinase |
| 05/10/2007 | WO2007053499A2 Compounds useful as antagonists of ccr2 |
| 05/10/2007 | WO2007053346A1 Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitors |
| 05/10/2007 | WO2007052843A1 Heterocyclic amide compound and use thereof |
| 05/10/2007 | WO2007052123A2 Pyrazine derivatives as sodium channel modulators for the treatment of pain |
| 05/10/2007 | WO2007052073A2 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
| 05/10/2007 | WO2007051982A1 Triazole compounds as lipoxygenase inhibitors |
| 05/10/2007 | WO2007024612A3 8-substituted benzoazepines as toll-like receptor modulators |
| 05/10/2007 | WO2007022934A3 Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine d3 receptors |
| 05/10/2007 | WO2006131835A3 Heterocyclic triazines as hypoxic selective protein kinase inhibitors |
| 05/10/2007 | WO2006105081A3 Pharmacokinetically improved compounds |
| 05/10/2007 | WO2006090167A3 Hydrazinomethyl, hydr zonomethyl and 5-membered heterocylic compounds which act as mtor inhibitors and their use as anti cancer agents |
| 05/10/2007 | US20070106077 Synthesis of substituted heterocyclic compounds |
| 05/10/2007 | US20070106075 Triazine based photoactive compound containing oxime ester |
| 05/10/2007 | US20070105988 shields light having such wavelength that reduces color purity while maintaining brightness in visible field (can reduce tinting caused by extra blue lights); provide clear images; improve colors |
| 05/10/2007 | US20070105936 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 05/10/2007 | US20070105935 Reacting 2-hydroxymethyl-n-protected-4-substituted pyrrolidine with arylsulfonyl chloride or an optionally substituted alkylsulfonyl chloride in the presence of a base; reacting with p-hydroxybenzenecarboxylic acid derivative (ethyl 4-(N-benzyloxycarbonyl-(4S)-methoxy-(2S)-pyrrolidinylmethoxy)benzoate) |
| 05/10/2007 | US20070105930 Methyl 4-[(3-methyl-4-methylsufonyl-2-{[4-(trifluoromethoxy)-phenyl]imino}-6-(trifluoromethyl)-2,3-dihydro-1H-benzimidazol-1-yl)methyl]benzoate; glucagon receptor antagonists; type 2 diabetes mellitus |
| 05/10/2007 | US20070105929 2, 4, 5 - Trisubstituted Imidazoles And Their Use As Anti-Microbial Agents |
| 05/10/2007 | US20070105927 Amorphous rizatriptan benzoate |
| 05/10/2007 | US20070105923 Substantially pure olmesartan medoxomil and processes for its preparation |
| 05/10/2007 | US20070105917 distinctly folded, amide bond is replaced by aromatic ring (1,2,3,-triazole) yet the chiral main chain and amino acid side chains are maintained; used as peptide mimics; diverse set of side chains without the limitations imposed by secondary amide bond; drug discovery; enzyme inhibitors; HIV protease |
| 05/10/2007 | US20070105909 Compounds useful in therapy |
| 05/10/2007 | US20070105907 Novel IDO inhibitors and methods of use thereof |
| 05/10/2007 | US20070105906 N-(1-{3-[(R)-2-[3-(phenylsulphonylamino)-phenyl]-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-indol-5-yl)-2-cyano-acetamide, used for treating non-insulin dependent diabetes, obesity or overactive bladder |
| 05/10/2007 | US20070105904 3-(3-(4-(pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine; inhibiting fungal GPI biosynthesis thereby inhibiting expression of cell wall proteins and blocking cell wall assembly while preventing the fungus from attaching to cells |
| 05/10/2007 | US20070105900 Pharmaceutical compounds |
| 05/10/2007 | US20070105898 Process for the production of cilostazol |
| 05/10/2007 | US20070105893 e.g. 2-[(4-Ethoxyphenyl)methyl]-1-(3-methylbutyl)-N,N-bis(2,2,2-trifluoroethyl)-1H-benzimidazole-5-carboxamide; agonists at cannabinoid 2 receptor; analgesic agent, anticarcinogenic agent, neurodegenerative diseases; multiple sclerosis, Parkinson's disease, Huntington's chorea or Alzheimer's disease. |
| 05/10/2007 | US20070105872 N-[6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl]-3-methylisoxazole-4-carboxamide; N-[6-amino-5-(2,3-dichloro-5-methoxyphenyl)pyrazin-2-yl]-1-methyl-1H-pyrazole-5-carboxamide |
| 05/10/2007 | US20070105871 1,3,4-Substituted pyrazoles as 5-ht receptor antagonists for the treatment of psychoses and neurological disorders |
| 05/10/2007 | US20070105866 5-lipoxygenase-activating protein (flap) inhibitors |
| 05/10/2007 | US20070105862 Heat-shock protein binders |
| 05/10/2007 | US20070105861 Novel vanilloid receptor ligands and use thereof for the production of pharmaceutical preparations |
| 05/10/2007 | US20070105858 Retinoic acid mimetic anilides |
| 05/10/2007 | US20070105855 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/10/2007 | US20070105854 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/10/2007 | US20070105853 2-'4-(Hydroxymethyl-phenylamino)-piperidine-1-yl!-n-(9h-carbazol-3-yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 05/10/2007 | US20070105842 purinergic receptor inhibitors; 5-[2-chloro-3-(trifluoromethyl)phenyl]-1-[2,3-dihydro-1H-inden-1-yl]-1H-1,2,4-triazole; [4-(2,3-Dichloro-phenyl)-4H-[1,2,4]triazol-3-yl]-(2-pyrrolidin-1-yl-pyridin-3-ylmethyl)-amine |
| 05/10/2007 | US20070105839 2, 4-Di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
| 05/10/2007 | US20070105838 Bicyclic Benzamide Compoundssa as Histamine H3 Receptor Ligand Useful in the Treatment of Neurological Diseases |
| 05/10/2007 | US20070105836 Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 05/10/2007 | US20070105834 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide |
| 05/10/2007 | US20070105833 including cystic fibrosis transmembrane conductance regulator ("CFTR"), such as 4-amido-pyrimidine compounds and derivatives, used for treating genetic disorders; respiratory system disorders |
| 05/10/2007 | US20070105820 Oxindole compounds and their uses as therapeutic agents |
| 05/10/2007 | US20070103060 Platinum complex and light emitting device |
| 05/10/2007 | CA2628259A1 Dihydroisoindolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2627892A1 Substituted dihydroisoindolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2627813A1 Substituted pyrrolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2627670A1 Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitors |
| 05/10/2007 | CA2627516A1 Triazole compounds as lipoxygenase inhibitors |
| 05/10/2007 | CA2627423A1 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
| 05/09/2007 | EP1783116A1 2-phenylpyridine derivative |
| 05/09/2007 | EP1781641A1 Pyrrolo-naphthyl acids as pai-1 inhibitors |
| 05/09/2007 | EP1781640A1 2,4-di(aminophenyl)pyrimidine derivatives as plk inhibitors |
| 05/09/2007 | EP1781638A2 Imidazolo-related compounds, compositions and methods for their use |
| 05/09/2007 | EP1781636A1 Pyrrole derivatives, their preparation and their therapeutic use |
| 05/09/2007 | EP1781623A1 Compounds and compositions useful as cathepsin s inhibitors |
| 05/09/2007 | EP1781620A1 Novel beta agonists, method for producing the same and their use as drugs |
| 05/09/2007 | EP1781619A1 Sigma receptor inhibitors |
| 05/09/2007 | EP1781618A1 Sigma receptor inhibitors |
| 05/09/2007 | EP1781617A2 Alpha, beta-unsaturated esters and acids by stereoselective dehydration |
| 05/09/2007 | EP1781606A2 Azetidine derivatives as ccr-3 receptor antagonists |
| 05/09/2007 | EP1781296A2 Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 05/09/2007 | EP1682530B1 Pyrrole substituted indoles as inhibitors of pai-1 |
| 05/09/2007 | EP1572667B1 Cathepsin cysteine protease inhibitors and their use in the treatment of inflammation and immune disorders |
| 05/09/2007 | EP1501796B1 3-(pyridinyl-amino)-1h-indole-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 05/09/2007 | EP1313712B1 Process and intermediates for preparing retroviral protease inhibitors |
| 05/09/2007 | EP1238970B9 Cycloamine ccr5 receptor antagonists |
| 05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 05/09/2007 | EP1183245B1 Selective npy (y5) antagonists |
| 05/09/2007 | CN1960988A Compounds and compositions as protein kinase inhibitors |
| 05/09/2007 | CN1960977A Quinazoline derivative |
| 05/09/2007 | CN1960976A 4-carbox pyrazole derivates useful as anti-viral agents |
| 05/09/2007 | CN1960971A Substituted pyrrolidine-2-ones |
| 05/09/2007 | CN1960970A Pyrrolidine derivatives as CB1-receptor antagonists |
| 05/09/2007 | CN1960969A Histamine H3 receptor agents, preparation method and therapeutic uses thereof |
| 05/09/2007 | CN1314739C Composition stabilized against thermal, oxidative or light-induced degradation and its preparing process |
| 05/09/2007 | CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 05/09/2007 | CN1314682C Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| 05/08/2007 | US7214802 Anti-cytokine heterocyclic compounds |
| 05/08/2007 | US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 05/08/2007 | US7214796 Converting hydroxyl group in 1-formyl-4-(2-hydroxyethyl) piperazine to a leaving group, reacting with 2-mercaptobenzimidazole , and removing the formyl group; formyl derivative is prepared by formylating 1-(2-hydroxyethyl)piperazine |
| 05/08/2007 | US7214700 Administering to a human patient an 2-oxindole-3-ylidenyl) acetic acid derivatives which modulate the activity of protein kinases and effective to treat disorders related to abnormal protein kinase activity, such as cancer |